Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 10Observational 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Recurrence 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urologic Neoplasms 1Urogenital Neoplasms 1Stomach Neoplasms 1Ovarian Neoplasms 1Neoplasms by Site 1Neoplasms by Histologic Type 1Neoplasms 1Fallopian Tube Neoplasms 1Colorectal Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Carcinoma 1Appendiceal Neoplasms 1

Interventions

Hyperthermic Intraperitoneal Chemotherapy 2Watchful Waiting 1Quality of Life 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Mitomycin 1Immunotherapy 1Drug Therapy 1Doxorubicin 1DNA Fingerprinting 1Colectomy 1Cisplatin 1Biological Therapy 1Appendectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Appendiceal Neoplasms × Mitomycin × Clear all
NCT03604653 2022-08-03

Trial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers

Holy Name Medical Center, Inc.

Completed
10 enrolled
GastrointestinalGynecologic

Appendiceal Neoplasms, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Uterine Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡